{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:20:56Z","timestamp":1790716856917,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","award":["CXCY2021009"],"award-info":[{"award-number":["CXCY2021009"]}],"id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","award":["K202011-1"],"award-info":[{"award-number":["K202011-1"]}],"id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"CSCO","doi-asserted-by":"publisher","award":["Y-Roche2019\/2-0061"],"award-info":[{"award-number":["Y-Roche2019\/2-0061"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.prp.2022.153781","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T22:18:37Z","timestamp":1643408317000},"page":"153781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma"],"prefix":"10.1016","volume":"231","author":[{"given":"Liu-qing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ke","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-fang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153781_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12185-016-2007-1","article-title":"Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma","volume":"104","author":"Makita","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.prp.2022.153781_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012120","article-title":"Epidemiologic characteristics of malignant lymphoma in Hubei, China: a single-center 5-year retrospective study","volume":"97","author":"Meng","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2022.153781_bib3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.153781_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.anndiagpath.2019.02.001","article-title":"American Registry of Pathology Expert Opinions: immunohistochemical evaluation of classic Hodgkin lymphoma","volume":"39","author":"O\u2019Malley","year":"2019","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2022.153781_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12026-011-8205-2","article-title":"Transcriptional regulation by STAT6","volume":"50","author":"Goenka","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.prp.2022.153781_bib6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2009.103","article-title":"STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line","volume":"23","author":"Baus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2022.153781_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","article-title":"Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma","volume":"104","author":"Guiter","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.153781_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.153781_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000049523","article-title":"Interleukin 13: a growth factor in hodgkin lymphoma","volume":"126","author":"Skinnider","year":"2001","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.prp.2022.153781_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153477","article-title":"STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology","volume":"223","author":"Karpathiou","year":"2021","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2022.153781_bib11","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.153781_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41379-019-0428-0","article-title":"Diagnostic utility of STAT6 expression in classical Hodgkin lymphoma and related entities","volume":"33","author":"Van Slambrouck","year":"2020","journal-title":"Mod. Pathol.: Off. J. U.S. Can. Acad. Pathol. Inc"},{"key":"10.1016\/j.prp.2022.153781_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood-2010-01-265272","article-title":"STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma","volume":"117","author":"Kis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.153781_bib14","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, JAMA, 310, 2013, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"10.1016\/j.prp.2022.153781_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12308-010-0059-3","article-title":"Epstein-Barr virus and Hodgkin\u2019s lymphoma in Cairo, Egypt","volume":"3","author":"Audouin","year":"2010","journal-title":"J. Hematop."},{"key":"10.1016\/j.prp.2022.153781_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pathol.2019.09.005","article-title":"Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis","volume":"52","author":"Piris","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.prp.2022.153781_bib17","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1080\/10428190310001623801","article-title":"Risk factors for Hodgkin\u2019s lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin\u2019s lymphoma","volume":"44 Suppl 3","author":"Jarrett","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2022.153781_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","article-title":"EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153781_bib19","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.10.010405","article-title":"Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence","volume":"10","author":"Bakkalci","year":"2020","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.prp.2022.153781_bib20","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1128\/JVI.77.7.4139-4148.2003","article-title":"A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus","volume":"77","author":"Chen","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.prp.2022.153781_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/cr.2008.41","article-title":"Roles of unphosphorylated STATs in signaling","volume":"18","author":"Yang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2022.153781_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod. Pathol.: Off. J. U.S. Can. Acad. Pathol. Inc"},{"key":"10.1016\/j.prp.2022.153781_bib23","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.prp.2018.07.011","article-title":"STAT6 expression in spindle cell lesions of the breast: an immunohistochemical study of 48 cases","volume":"214","author":"Magro","year":"2018","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2022.153781_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2018.02.016","article-title":"STAT6 is a cargo of exportin 1: biological relevance in primary mediastinal B-cell lymphoma","volume":"46","author":"Miloudi","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prp.2022.153781_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:25:00Z","timestamp":1778747100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":25,"alternative-id":["S0344033822000243"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153781","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153781"}}